Literature DB >> 18450611

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Edwin Bölke, Matthias Peiper, Wilfried Budach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450611     DOI: 10.1056/NEJMc080178

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.

Authors:  Yi-Fan Li; Hou-Ting Zhang; Lin Xin
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-01       Impact factor: 4.553

2.  Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer.

Authors:  Tian-Jie Qin; Gai-Li An; Xin-Han Zhao; Fang Tian; Xiao-Hua Li; Juan-Wen Lian; Bo-Rong Pan; Shan-Zhi Gu
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

3.  Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma.

Authors:  Mengzhou Guo; Yiyi Yu; Yan Wang; Yuehong Cui; Qian Li; Yi Feng; Wei Li; RongYuan Zhuang; Tianshu Liu
Journal:  Med Oncol       Date:  2015-08-13       Impact factor: 3.064

4.  Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer.

Authors:  Yasutsuna Sasaki; Tomohiro Nishina; Hirofumi Yasui; Masahiro Goto; Kei Muro; Akihito Tsuji; Wasaburo Koizumi; Yasushi Toh; Takuo Hara; Yoshinori Miyata
Journal:  Cancer Sci       Date:  2014-07-07       Impact factor: 6.716

5.  Short-term efficacy of different chemotherapy regimens in the treatment of advanced gastric cancer: a network meta-analysis.

Authors:  Mi-Ma Duo-Ji; Ba-Sang Ci-Ren; Zi-Wen Long; Xiao-Hua Zhang; Dong-Lin Luo
Journal:  Oncotarget       Date:  2017-06-06

6.  Downregulation of Annexin A11 (ANXA11) Inhibits Cell Proliferation, Invasion, and Migration via the AKT/GSK-3β Pathway in Gastric Cancer.

Authors:  Kelei Hua; Yong Li; Qun Zhao; Liqiao Fan; Bibo Tan; Jianbin Gu
Journal:  Med Sci Monit       Date:  2018-01-07

7.  Durable Response After Combination Of Concurrent Chemoradiotherapy And Anti-PD-1 Therapy In HER2-Negative Advanced Gastric Adenocarcinoma: A Case Report.

Authors:  Shanshan Yu; Luya Cai; Fan Lin; Xueyuan Wu; Cheng Zhang; Xuan Liu; Wenfeng Li
Journal:  Onco Targets Ther       Date:  2019-09-19       Impact factor: 4.147

8.  Babao Dan inhibits the migration and invasion of gastric cancer cells by suppressing epithelial-mesenchymal transition through the TGF-β/Smad pathway.

Authors:  Jianxin Liu; Yongan Chen; Zhiyun Cao; Bin Guan; Jun Peng; Youqin Chen; Zhixue Zhan; Thomas Joseph Sferra; Senthilkumar Sankararaman; Jiumao Lin
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.